(Total Views: 470)
Posted On: 07/31/2021 1:42:40 PM
Post# of 148924
Yes, it would seem that Gilead has more interest in immunotherapies than advertised. (We know why).
Seems they have less publicized partnerships on the cheap that most are not aware of.
I have recently been looking at GRTS. Similar approach, different MOA, but definitely a "fear of CYDY" looksee imho. To date, no buyout. In their efforts to get around us, they affirm the molecule. Nothing better out there.
Seems they have less publicized partnerships on the cheap that most are not aware of.
I have recently been looking at GRTS. Similar approach, different MOA, but definitely a "fear of CYDY" looksee imho. To date, no buyout. In their efforts to get around us, they affirm the molecule. Nothing better out there.
(0)
(0)Scroll down for more posts ▼
